Jiang, J.Zhao, M.Zhang, A.Yu, M.Lin, X.Wu, M.Wang, X.Lu, H.Zhu, S.Yu, Y.Mao, Z.Han, W.2025-12-172025-12-172010Biomedicine & Pharmacotherapy, 2010; 64(7):482-4860753-33221950-6007https://hdl.handle.net/1959.8/160822Wnt signaling pathway plays important roles in the biology of stem cells in maintaining their selfrenewal property. Glycogen synthase kinase-3 (GSK-3) inhibitors, the Wnt signaling agonists, maintain the pluripotency of embryonic stem cells. We report here that a synthetic GSK-3 inhibitor, 6- bromoindirubin-30-oxime (BIO), showed opposite effects on the expansion of human primitive hematopoietic cells isolated from umbilical cord blood (UCB). In combination with human c-kit ligand (KL), BIO at low concentration (0.2 mM) enhanced the expansion of UCB CD34+ cells, which was BIO structure and exposure time dependent; however, at high concentration (2 mM) it inhibited the expansion of the cells. Furthermore, hematopoietic stem cells (HSCs) were exhausted when the UCB CD34+ cells were exposed to 0.2 mM BIO and KL longer than 2 days. In conclusion, the use of BIO in expansion of UCB HSCs remains a significant challenge.enCopyright 2010 Elsevier Masson SAShuman umbilical cord bloodCD34+ cellsGSK-3 inhibitorBIOWnt signalingJournal article10.1016/j.biopha.2010.01.005000282151000008